NEVVI Medicare utilization intelligence

← back

SAHIN, MUSTAFAMD NPI 1235200320 Clinician

Hematology-Oncology · MELBOURNE, FL

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 37 years since medical school (class of 1989, self-reported to CMS)
Location MELBOURNE, FL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 48 codes billed · 86,621 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
HEALTH FIRST MEDICAL GROUP, LLC
2023–2026
LAKE REGION HEALTHCARE CORPORATION
2020–2022
RAPID CITY REGIONAL HOSPITAL INC
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-05

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
J9395 Injection, fulvestrant, 25 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J9045 Injection, carboplatin, 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
36591 Collection of blood sample from implanted device
96415 Administration of chemotherapy into vein, each additional hour
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
36430 Transfusion of blood or blood products
P9016 Red blood cells, leukocytes reduced, each unit
96361 Infusion into a vein for hydration, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96523 Irrigation of implanted venous access drug delivery device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
99195 Drawing of blood for a medical problem

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.